Tapewire

Nasdaq · USD

LFST

LifeStance Health Group, Inc.

Export transactions ↓
Tapewire entity
3936
SEC CIK
0001845257
Parsed reports
271

Last 12 months

Inside the activity.

0 purchase rows · 37 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202501
Dec 2025011
Jan 202600
Feb 202600
Mar 202602
Apr 202606
May 202607
Jun 202602
Jul 202600
Aug 202606
Sep 202602
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 22, 2023 Filed Jun 23, 2023 16:31 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 57,754 $9.05 $522,673.70
Disclosure

SEC source: 0000950170-23-029655 · ownership.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,868,228

F1 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
June 21, 2023 Filed Jun 22, 2023 16:30 UTC SaleCommon Stock 587 $9.07 $5,324.09
Disclosure

SEC source: 0000899243-23-016246 · doc4.xml · nonDerivative · entry 2

Qureshi Danish J. · CIK 0001864331 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,583,404

F1 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
June 21, 2023 Filed Jun 22, 2023 16:30 UTC SaleCommon Stock 71,811 $9.03 $648,453.33
Disclosure

SEC source: 0000899243-23-016246 · doc4.xml · nonDerivative · entry 1

Qureshi Danish J. · CIK 0001864331 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,583,991

F1 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

Read SEC document
June 14, 2023 Filed Jun 15, 2023 17:24 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 45,984 $8.95 $411,556.80
Disclosure

SEC source: 0000899243-23-015627 · doc4.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,925,982

Read SEC document
June 13, 2023 Filed Jun 14, 2023 16:31 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 47,142 $8.71 $410,606.82
Disclosure

SEC source: 0000950170-23-027977 · ownership.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,971,966

Read SEC document
June 12, 2023 Filed Jun 13, 2023 17:47 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 2,858 $8.51 $24,321.58
Disclosure

SEC source: 0000950170-23-027784 · ownership.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,019,108

Read SEC document
April 04, 2023 Filed Apr 6, 2023 17:00 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 4,785 $7.62 $36,461.70
Disclosure

SEC source: 0000899243-23-010866 · doc4.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,021,966

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
April 04, 2023 Filed Apr 6, 2023 21:00 UTC
Pardo RyanSee Remarks
SaleCommon Stock 6,398 $7.62 $48,752.76
Disclosure

SEC source: 0000899243-23-010863 · doc4.xml · nonDerivative · entry 1

Pardo Ryan · CIK 0001865531 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 686,597

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
April 04, 2023 Filed Apr 6, 2023 17:00 UTC
Patel-Dunn AnishaChief Medical Officer
SaleCommon Stock 7,319 $7.62 $55,770.78
Disclosure

SEC source: 0000899243-23-010861 · doc4.xml · nonDerivative · entry 1

Patel-Dunn Anisha · CIK 0001864311 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 279,657

F1 · kind: Required number of shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
April 04, 2023 Filed Apr 6, 2023 17:00 UTC SaleCommon Stock 8,775 $7.62 $66,865.50
Disclosure

SEC source: 0000899243-23-010862 · doc4.xml · nonDerivative · entry 1

Qureshi Danish J. · CIK 0001864331 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,655,802

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
April 04, 2023 Filed Apr 6, 2023 17:10 UTC
Mullins Kevin MichaelChief Development Officer
SaleCommon Stock 69,734 $7.61 $530,675.74
Disclosure

SEC source: 0000899243-23-010874 · doc4.xml · nonDerivative · entry 1

Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,436,448

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.46 to $7.77 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 04, 2023 Filed Apr 6, 2023 17:00 UTC
Mullins Kevin MichaelChief Development Officer
SaleCommon Stock 6,399 $7.62 $48,760.38
Disclosure

SEC source: 0000899243-23-010864 · doc4.xml · nonDerivative · entry 1

Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,506,182

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
April 04, 2023 Filed Apr 6, 2023 17:00 UTC
Pantaleoni PabloChief Medical Officer
SaleCommon Stock 6,435 $7.62 $49,034.70
Disclosure

SEC source: 0000899243-23-010865 · doc4.xml · nonDerivative · entry 1

Pantaleoni Pablo · CIK 0001864258 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,126,474

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
April 03, 2023 Filed Apr 4, 2023 20:00 UTC
Mullins Kevin MichaelChief Development Officer
SaleCommon Stock 97,266 $7.43 $722,686.38
Disclosure

SEC source: 0000899243-23-010555 · doc4.xml · nonDerivative · entry 1

Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,512,581

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on December 9, 2022.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.17 to $7.53 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 16, 2023 Filed Mar 17, 2023 16:30 UTC
Mullins Kevin MichaelChief Development Officer
SaleCommon Stock 43,705 $6.14 $268,348.70
Disclosure

SEC source: 0000899243-23-008876 · doc4.xml · nonDerivative · entry 2

Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,609,847

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.11 to $6.23 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 15, 2023 Filed Mar 17, 2023 16:30 UTC
Mullins Kevin MichaelChief Development Officer
SaleCommon Stock 200 $6.11 $1,222.00
Disclosure

SEC source: 0000899243-23-008876 · doc4.xml · nonDerivative · entry 1

Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,653,552

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 14, 2023 Filed Mar 15, 2023 17:51 UTC
Mullins Kevin MichaelChief Development Officer
SaleCommon Stock 800 $6.11 $4,888.00
Disclosure

SEC source: 0000899243-23-008603 · doc4.xml · nonDerivative · entry 1

Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,653,752

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
March 08, 2023 Filed Mar 10, 2023 17:00 UTC
Mullins Kevin MichaelChief Development Officer
SaleCommon Stock 122,295 $6.12 $748,445.40
Disclosure

SEC source: 0000899243-23-008136 · doc4.xml · nonDerivative · entry 1

Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,654,552

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $6.11 to $6.22 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 22:18 UTC
Pardo RyanSee Remarks
GrantCommon Stock 192,307 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-007557 · doc4.xml · nonDerivative · entry 1

Pardo Ryan · CIK 0001865531 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 692,995

F1 · shares: Includes 192,307 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 17:19 UTC
Patel-Dunn AnishaChief Medical Officer
GrantCommon Stock 192,307 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-007558 · doc4.xml · nonDerivative · entry 1

Patel-Dunn Anisha · CIK 0001864311 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 286,976

F1 · shares: Includes 192,307 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 17:20 UTC
Gouk WarrenChief Administrative Officer
GrantCommon Stock 58,760 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-007560 · doc4.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,026,751

F1 · shares: Includes 58,760 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 17:22 UTC GrantCommon Stock 320,512 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-007566 · doc4.xml · nonDerivative · entry 1

Qureshi Danish J. · CIK 0001864331 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,664,577

F1 · shares: Includes 320,512 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 17:19 UTC
Mullins Kevin MichaelChief Development Officer
GrantCommon Stock 192,307 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-007559 · doc4.xml · nonDerivative · entry 1

Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,776,847

F1 · shares: Includes 192,307 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 17:23 UTC
Pantaleoni PabloChief Digital Officer
GrantCommon Stock 197,649 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-007567 · doc4.xml · nonDerivative · entry 1

Pantaleoni Pablo · CIK 0001864258 · Chief Digital Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,132,909

F1 · shares: Includes 197,649 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 22:18 UTC
Burdick Kenneth ADirector · Chief Executive Officer
GrantCommon Stock 544,871 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-007556 · doc4.xml · nonDerivative · entry 2

Burdick Kenneth A · CIK 0001498992 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,361,110

F2 · shares: Includes 544,871 RSUs. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 22:18 UTC
Burdick Kenneth ADirector · Chief Executive Officer
GrantCommon Stock 1,816,239 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-007556 · doc4.xml · nonDerivative · entry 1

Burdick Kenneth A · CIK 0001498992 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,816,239

F1 · shares: Includes 1,816,239 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 17:25 UTC
Bourdon DavidChief Financial Officer
GrantCommon Stock 160,256 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-007568 · doc4.xml · nonDerivative · entry 1

Bourdon David · CIK 0001823690 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,016

F1 · shares: Includes 160,256 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
March 06, 2023 Filed Mar 8, 2023 22:21 UTC
Varanakis AnnChief People Officer
GrantCommon Stock 96,153 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-007563 · doc4.xml · nonDerivative · entry 1

Varanakis Ann · CIK 0001965703 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 174,102

F1 · shares: Includes 96,153 restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Read SEC document
November 10, 2022 Filed Nov 14, 2022 17:35 UTC
Bourdon DavidChief Financial Officer
GrantStock Option (right to buy) · Derivative 1,250,000 $0.00 Strike: $5.53 $0.00
Disclosure

SEC source: 0000899243-22-035720 · doc4.xml · derivative · entry 3

Bourdon David · CIK 0001823690 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,250,000

Underlying: Common Stock · 1,250,000 shares

Expires 2032-11-10

F1 · shares: The options were granted by the Issuer pursuant to the LifeStance Health Group, Inc. 2021 Equity Incentive Plan.

F2 · derivative.exercise_date: Includes an option to purchase 416,666 shares of the Issuer's common stock, subject to time-based vesting (the "Time-Vesting Option"). The Time-Vesting Option vests as to 25% on each of the first four anniversaries of the vesting commencement date, November 10, 2022. Includes an option to purchase 833,334 shares of the Issuer's common stock, subject to time- and performance-based vesting (the "Performance-Vesting Option"). The Performance-Vesting Option vests as to up to 25% on each of the first four anniversaries of the vesting commencement date, November 10, 2022. Following each anniversary of the vesting commencement date, any portion of the Performance-Vesting Option eligible to vest as of such measurement date that did not vest pursuant to the performance-based vesting criteria will be eligible to vest on a quarterly basis thereafter, subject to the same performance-based vesting criteria.

Read SEC document
November 10, 2022 Filed Nov 14, 2022 17:35 UTC
Bourdon DavidChief Financial Officer
Tax withholdingCommon Stock 77,072 $5.53 $426,208.16
Disclosure

SEC source: 0000899243-22-035720 · doc4.xml · nonDerivative · entry 2

Bourdon David · CIK 0001823690 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 103,760

Read SEC document
November 10, 2022 Filed Nov 14, 2022 17:35 UTC
Bourdon DavidChief Financial Officer
GrantCommon Stock 180,832 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-035720 · doc4.xml · nonDerivative · entry 1

Bourdon David · CIK 0001823690 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,832

Read SEC document
November 07, 2022 Filed Nov 9, 2022 07:00 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 15,106 $7.20 $108,763.20
Disclosure

SEC source: 0000899243-22-035404 · doc4.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,967,991

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.13 to $7.29 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 31, 2022 Filed Nov 2, 2022 16:35 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 15,106 $7.49 $113,143.94
Disclosure

SEC source: 0000899243-22-034764 · doc4.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,983,097

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.38 to $7.64 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 24, 2022 Filed Oct 26, 2022 17:00 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 15,106 $7.06 $106,648.36
Disclosure

SEC source: 0000899243-22-034278 · doc4.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,998,203

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.11 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 17, 2022 Filed Oct 19, 2022 16:30 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 15,106 $8.01 $120,999.06
Disclosure

SEC source: 0000899243-22-033823 · doc4.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,013,309

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.80 to $8.19 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 10, 2022 Filed Oct 11, 2022 17:00 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 15,106 $7.45 $112,539.70
Disclosure

SEC source: 0000899243-22-033401 · doc4.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,028,415

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.26 to $7.70 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
October 03, 2022 Filed Oct 5, 2022 17:45 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 15,106 $7.02 $106,044.12
Disclosure

SEC source: 0000899243-22-033043 · doc4.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,043,521

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.09 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 30, 2022 Filed Oct 3, 2022 16:33 UTC
Mullins Kevin MichaelChief Development Officer
SaleCommon Stock 82,520 $7.03 $580,115.60
Disclosure

SEC source: 0000899243-22-032431 · doc4.xml · nonDerivative · entry 1

Mullins Kevin Michael · CIK 0001864233 · Chief Development Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,584,540

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.20 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 08, 2022 Filed Sep 9, 2022 19:10 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 51,672 $9.01 $465,564.72
Disclosure

SEC source: 0000899243-22-030753 · doc4.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,058,627

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $9.00 to $9.07 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
September 07, 2022 Filed Sep 9, 2022 19:11 UTC GrantStock Option (right to buy) · Derivative 2,821,362 $0.00 Strike: $7.61 $0.00
Disclosure

SEC source: 0000899243-22-030755 · doc4.xml · derivative · entry 1

Qureshi Danish J. · CIK 0001864331 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,821,362

Underlying: Common Stock · 2,821,362 shares

Expires 2032-09-07

F1 · shares: The options were granted by the Issuer pursuant to the LifeStance Health Group, Inc. 2021 Equity Incentive Plan.

F2 · derivative.exercise_date: Includes an option to purchase 940,454 shares of the Issuer's common stock, subject to time-based vesting (the "Time-Vesting Option"). The Time-Vesting Option vests as to 25% on each of the first four anniversaries of the vesting commencement date, September 7, 2022. Includes an option to purchase 1,880,908 shares of the Issuer's common stock, subject to time- and performance-based vesting (the "Performance-Vesting Option"). The Performance-Vesting Option vests as to up to 25% on each of the first four anniversaries of the vesting commencement date, September 7, 2022. Following each anniversary of the vesting commencement date, any portion of the Performance-Vesting Option eligible to vest as of such measurement date that did not vest pursuant to the performance-based vesting criteria will be eligible to vest on a quarterly basis thereafter, subject to the same performance-based vesting criteria.

Read SEC document
September 07, 2022 Filed Sep 9, 2022 23:11 UTC
Burdick Kenneth ADirector · Chief Executive Officer
GrantStock Option (right to buy) · Derivative 9,404,539 $0.00 Strike: $7.61 $0.00
Disclosure

SEC source: 0000899243-22-030756 · doc4.xml · derivative · entry 1

Burdick Kenneth A · CIK 0001498992 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,404,539

Underlying: Common Stock · 9,404,539 shares

Expires 2032-09-07

F1 · shares: The options were granted by the Issuer pursuant to the LifeStance Health Group, Inc. 2021 Equity Incentive Plan.

F2 · derivative.exercise_date: Includes an option to purchase 3,134,846 shares of the Issuer's common stock, subject to time-based vesting (the "Time-Vesting Option"). The Time-Vesting Option vests as to 25% on each of the first four anniversaries of the vesting commencement date, September 7, 2022. Includes an option to purchase 6,269,693 shares of the Issuer's common stock, subject to time- and performance-based vesting (the "Performance-Vesting Option"). The Performance-Vesting Option vests as to up to 25% on each of the first four anniversaries of the vesting commencement date, September 7, 2022. Following each anniversary of the vesting commencement date, any portion of the Performance-Vesting Option eligible to vest as of such measurement date that did not vest pursuant to the performance-based vesting criteria will be eligible to vest on a quarterly basis thereafter, subject to the same performance-based vesting criteria.

Read SEC document
September 06, 2022 Filed Sep 8, 2022 17:00 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 34,449 $7.00 $241,143.00
Disclosure

SEC source: 0000899243-22-030682 · doc4.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,110,299

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
August 23, 2022 Filed Aug 24, 2022 17:15 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 17,226 $7.02 $120,926.52
Disclosure

SEC source: 0000899243-22-029613 · doc4.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,144,748

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.11 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 15, 2022 Filed Aug 16, 2022 16:00 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 17,226 $7.85 $135,224.10
Disclosure

SEC source: 0000899243-22-028779 · doc4.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,161,974

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.66 to $8.10 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 08, 2022 Filed Aug 10, 2022 17:00 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 17,226 $7.30 $125,749.80
Disclosure

SEC source: 0000899243-22-028262 · doc4.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,179,200

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.20 to $7.42 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
August 03, 2022 Filed Aug 5, 2022 16:15 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 68,904 $7.00 $482,328.00
Disclosure

SEC source: 0000899243-22-027829 · doc4.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,196,426

F1 · kind: The reported transactions were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: These shares were sold in multiple transactions. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at in each transaction for $7.00.

Read SEC document
June 13, 2022 Filed Jun 14, 2022 16:40 UTC
Gouk WarrenChief Administrative Officer
SaleCommon Stock 67,479 $5.32 $358,988.28
Disclosure

SEC source: 0000899243-22-022392 · doc4.xml · nonDerivative · entry 1

Gouk Warren · CIK 0001865503 · Chief Administrative Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,275,330

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
June 13, 2022 Filed Jun 14, 2022 20:44 UTC
Pardo RyanSee Remarks
SaleCommon Stock 56,370 $5.35 $301,579.50
Disclosure

SEC source: 0000899243-22-022402 · doc4.xml · nonDerivative · entry 1

Pardo Ryan · CIK 0001865531 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 500,688

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
June 13, 2022 Filed Jun 14, 2022 16:41 UTC
Gorcyca FeliciaChief People Officer
SaleCommon Stock 2,638 $5.33 $14,060.54
Disclosure

SEC source: 0000899243-22-022394 · doc4.xml · nonDerivative · entry 1

Gorcyca Felicia · CIK 0001865529 · Chief People Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 909,582

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document
June 13, 2022 Filed Jun 14, 2022 16:42 UTC
Booth Gwen H.Chief Operating Officer
SaleCommon Stock 88,798 $5.27 $467,965.46
Disclosure

SEC source: 0000899243-22-022395 · doc4.xml · nonDerivative · entry 1

Booth Gwen H. · CIK 0001864862 · Chief Operating Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,083,637

F1 · kind: Required number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale was made to satisfy tax withholding obligations through a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.